Credit Suisse’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-32,500
Closed -$3.23M 4482
2019
Q3
$3.23M Hold
32,500
﹤0.01% 2110
2019
Q2
$3M Sell
32,500
-3,300
-9% -$313K ﹤0.01% 2147
2019
Q1
$3.38M Sell
35,800
-500,700
-93% -$43.8M ﹤0.01% 2003
2018
Q4
$34.4M Buy
536,500
+219,600
+69% +$16.2M 0.04% 522
2018
Q3
$28.4M Buy
316,900
+96,100
+44% +$8.49M 0.03% 691
2018
Q2
$17.5M Buy
220,800
+175,500
+387% +$14.6M 0.02% 917
2018
Q1
$4.04M Sell
45,300
-64,200
-59% -$6.16M ﹤0.01% 1863
2017
Q4
$11.4M Buy
109,500
+54,200
+98% +$6.12M 0.01% 1188
2017
Q3
$8.06M Buy
55,300
+5,300
+11% +$722K 0.01% 1391
2017
Q2
$6.49M Sell
50,000
-98,800
-66% -$12.1M 0.01% 1461
2017
Q1
$18.5M Buy
148,800
+38,800
+35% +$4.64M 0.02% 862
2016
Q4
$12.7M Buy
110,000
+10,000
+10% +$1.11M 0.01% 1058
2016
Q3
$10.5M Buy
+100,000
New +$10.8M 0.01% 1157
2015
Q2
Sell
-10,800
Closed -$1.25M 4789
2015
Q1
$1.25M Buy
+10,800
New +$1.29M ﹤0.01% 2794
2014
Q3
Sell
-125,200
Closed -$10.8M 4901
2014
Q2
$10.8M Buy
+125,200
New +$9.52M 0.01% 1339

Other funds holding CELG

Credit Suisse's CELG Position: Q4 2019 in Review

Credit Suisse sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,893,749 shares — an estimated $685M sold.

Credit Suisse first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $685M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Credit Suisse reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Credit Suisse sold 6,893,749 Celgene Corp shares in Q4 2019, an estimated $685M.
  • Credit Suisse first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Credit Suisse's Celgene Corp position peaked at $685M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.